The U.S. Food and Drug Administration (FDA) issued a new communication this month alerting patients and healthcare professionals about reports of squamous cell carcinoma (SCC) and various lymphomas associated with breast implants. This is separate from what the World Health Organization (WHO) classified as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in 2016. While the FDA does not currently recommend preventative implant removal for patients who don’t have any symptoms or complications, some women with breast implants may want to have their implants removed anyway. “According to studies conducted by implant manufacturers, about 50% of breast implants need another surgery within 7 years,” says plastic surgeon Dr. Constance M. Chen.

Click HERE for the full article.